Skip to main content
Fig. 1 | Trials

Fig. 1

From: Vitamin D and omega-3 fatty acid supplements in children with autism spectrum disorder: a study protocol for a factorial randomised, double-blind, placebo-controlled trial

Fig. 1

Schematic diagram of study design. 1Blood biomarkers: 25-hydroxyvitamin D (25(OH)D), red blood cell (RBC) fatty acids, calcium, albumin, iron studies, vitamin B12, folate, full blood count and vitamin A. Questionnaires: sociodemographics, medical history, eating/mealtime behaviours and food diary. 2Questionnaires: sociocommunicative functioning, sensory problems and aberrant behaviours (primary outcomes); gastrointestinal symptoms (secondary outcome), sun exposure and skin colour. Anthropometry: weight and height. 3Blood biomarkers: 25(OH)D, RBC fatty acids, calcium and albumin. Questionnaires: sociocommunicative functioning, sensory problems, aberrant behaviours (primary outcomes) and eating/mealtime behaviours and diet quality. Anthropometry: weight and height. 4Blood biomarkers: 25(OH)D, calcium and albumin. *Gastrointestinal symptoms (secondary outcome) and medication/supplement use/incidence of adverse events/supplement compliance will be monitored throughout the study period

Back to article page

Trials

ISSN: 1745-6215